Literature DB >> 23448227

Heritability estimates of tarsocrural osteochondrosis and palmar/plantar first phalanx osteochondral fragments in Standardbred trotters.

S Lykkjen1, H F Olsen, N I Dolvik, A M Grøndahl, K H Røed, G Klemetsdal.   

Abstract

REASONS FOR PERFORMING STUDY: The pathogenesis of osteochondrosis (OC) and palmar/plantar first phalanx osteochondral fragments (POFs) is multifactorial, but specific knowledge of heritability is limited.
OBJECTIVES: To improve the precision of heritability estimates and to estimate the genetic correlation between tarsocrural OC and POFs in Standardbred trotters. Further aims were to examine whether the prevalence of OC/POFs was different in the American and French lineages that have contributed to the Norwegian population, and if the prevalence was affected by heterozygosity. STUDY
DESIGN: Retrospective cohort study.
METHODS: Categorical data on tarsocrural OC and POFs from 2 radiographic studies performed in 1989 and 2007/2008 (n = 1217) were analysed with sire threshold models that included 230 sires.
RESULTS: Heritability of OC at the distal intermediate ridge of the tibia and/or the lateral trochlear ridge of the talus was estimated at 0.29 ± 0.15. For OC at the distal intermediate ridge of the tibia only, the estimate was 0.40 ± 0.17. Heritability of POFs in all 4 limbs was estimated at 0.23 ± 0.13; for metatarsophalangeal POFs this was 0.26 ± 0.13 and for medial metatarsophalangeal POFs 0.32 ± 0.14. Estimates of genetic correlation between OC and POFs ranged from 0.68 ± 0.27 to 0.73 ± 0.28 but were not significantly different from a zero-genetic correlation. Effects of lineages or heterozygosity were not observed. CONCLUSIONS AND POTENTIAL RELEVANCE: This study confirmed a moderate to high heritability of tarsocrural OC and POF, providing further evidence of the heritable nature of these diseases. Examination of specific lesions yielded the highest heritability; therefore, breeding programmes and future genome-analysis studies should focus on predilection sites rather than the entire disease complex.
© 2013 EVJ Ltd.

Entities:  

Keywords:  Standardbred; heritability; horse; osteochondral fragment; osteochondrosis

Mesh:

Year:  2013        PMID: 23448227     DOI: 10.1111/evj.12058

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  6 in total

1.  Analysis of Genetic Diversity in the American Standardbred Horse Utilizing Short Tandem Repeats and Single Nucleotide Polymorphisms.

Authors:  Elizabeth Esdaile; Felipe Avila; Rebecca R Bellone
Journal:  J Hered       Date:  2022-07-09       Impact factor: 2.679

2.  Omics technologies provide new insights into the molecular physiopathology of equine osteochondrosis.

Authors:  Clémence Desjardin; Julie Riviere; Anne Vaiman; Caroline Morgenthaler; Mathieu Diribarne; Michel Zivy; Céline Robert; Laurence Le Moyec; Laurence Wimel; Olivier Lepage; Claire Jacques; Edmond Cribiu; Laurent Schibler
Journal:  BMC Genomics       Date:  2014-10-31       Impact factor: 3.969

3.  Identification and validation of risk loci for osteochondrosis in standardbreds.

Authors:  Annette M McCoy; Samantha K Beeson; Rebecca K Splan; Sigrid Lykkjen; Sarah L Ralston; James R Mickelson; Molly E McCue
Journal:  BMC Genomics       Date:  2016-01-12       Impact factor: 3.969

Review 4.  Osteochondritis dissecans (OCD) in Horses - Molecular Background of its Pathogenesis and Perspectives for Progenitor Stem Cell Therapy.

Authors:  Lynda Bourebaba; Michael Röcken; Krzysztof Marycz
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

5.  Consequences of the natural course of articular osteochondrosis in pigs for the suitability of computed tomography as a screening tool.

Authors:  Kristin Olstad; Jørgen Kongsro; Eli Grindflek; Nils I Dolvik
Journal:  BMC Vet Res       Date:  2014-09-09       Impact factor: 2.741

6.  Heritability and prevalence of selected osteochondrosis lesions in yearling Thoroughbred horses.

Authors:  J Russell; O Matika; T Russell; R J M Reardon
Journal:  Equine Vet J       Date:  2016-09-04       Impact factor: 2.888

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.